BIOVF - Swedish Orphan Biovitrum AB's (BIOVF) CEO Guido Oelkers on Merger & Acquisition Conference - Transcript
Swedish Orphan Biovitrum AB (BIOVF)
Merger & Acquisition Conference Call
November 13, 2018 8:00 AM ET
Executives
Guido Oelkers — Chief Executive Officer
Henrik Stenqvist — Chief Financial Officer
Milan Zdravkovic — Head-R&D
Analysts
Peter Sehested — Handelsbanken
Erik HultgÃ¥rd — Carnegie
Peter Östling — Pareto Securities
Kerry Holford — Exane BNP Paribas
Christopher Uhde — ABG Sundahl Collier
Manish Sharma — Deutsche Bank
Peter Sehested — Handelsbanken
Richard Koch — SEB
Presentation
Operator
Ladies and gentlemen, welcome to the Sobi to Acquire Synagis U.S. Rights from AstraZeneca Webcast. I’ll now hand over to Guido